Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xatral for stone clearance and pain after ESWL
NCT00388271Phase 3Withdrawn
- Sponsor
- Singapore General Hospital
- Start
- Oct 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alfuzosin in urinary calculi, sponsored by Singapore General Hospital. Planned start Oct 2006; status: withdrawn.
02
Drugs
alfuzosin
03
Conditions
urinary calculi
Beyond the preview
Go deeper on NCT00388271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00388271.